[Analysis of the effect of risk factors at gestational diabetes mellitus].

OBJECTIVE: To assesment the effect of risk factors at gestational diabetes mellitus (GDM). METHODS: We collected 427 pregnant women who had done 75 g oral glucose tolerance test (OGTT) between September 1(st), 2012 and April 19(th), 2013 in Peking University First Hospital, including 74 pregnant women diagnosed as GDM (GDM group) and 353 pregnant women undiagnosed (non-GDM group). Then we conducted a multiple logistic regression to analyze the clinical datas collected from two groups, which included age, pre-pregnancy body weight and body mass index (BMI), body weight during 11-12 weeks pregnancy, body weight during 23-24 weeks pregnancy; and fasting plasma glucose (FPG), triglyceride (TG) , total cholesterol (TCH) , high density lipoprotein (HDL) , low density lipoprotein (LDL), fasting insulin (FINS), homeostasis model assessment of insulin resistance (HOMA-IR) during early pregnancy; and family history of diabetes mellitus. RESULTS: (1) There were significant difference in age, pre-pregnancy BMI, and FPG, TG, FINS, HOMA-IR during early pregnancy, and family history of diabetes mellitus between two groups (P < 0.05). (2) The risk factors of GDM that have statistical significance included FPG during early pregnancy (OR:4.03, 95%CI:1.62-10.02), family history of diabetes mellitus (OR:3.15, 95%CI:1.66-5.99), TG during early pregnancy (OR:2.13, 95%CI:1.17-3.87),BMI before pregnancy (OR:1.36, 95%CI:1.08-1.70), age ≥ 35 years (OR:1.15, 95%CI:1.05-1.26), early pregnancy weight gain (OR:1.20, 95%CI:1.06-1.35), mid pregnancy weight gain (OR:1.28, 95%CI:1.12-1.47), FINS during early pregnancy (OR:1.09, 95%CI:1.01-1.17). CONCLUSIONS: FPG, TG and FINS during early pregnancy, BMI before pregnancy, early and mid pregnancy weight gain, family history of diabetes mellitus and age ≥ 35 years are the indepadent risk factors for GDM. We should pay more attention to FPG and TG during early pregnancy, and put weight management into practise since early pregnancy and try to control pregnancy weight gain within reasonable limits.

Data mining and analysis for ADE signals of three third-generation tetracycline antibiotics / 中国药房

OBJECTIVE To excavate the adverse drug event （ADE） signals of three third-generation tetracycline antibiotics （tigecycline， omadacycline， eravacycline） based on FDA adverse event reporting system （FAERS）， and to provide reference for the safe use of them. METHODS The ADE reports of tigecycline， omadacycline and eravacycline from the first quarter of 2005 to the second quarter of 2023 were retrieved from FAERS database. The ADE signals of 3 kinds of drugs were mined by the method of reporting odds ratio method and the proportional reporting ratio method. RESULTS Totally 2 538 ADE reports with tigecycline， omadacycline and eravacycline as the primary suspected drugs were obtained， including 2 135 tigecycline ADE reports， 349 omadacycline ADE reports and 54 eravacycline ADE reports. A total of 131 ADE positive signals of tigecycline were mined， involving 19 system organ classes （SOCs）， mainly concentrated in investigations， hepatobiliary system， blood and lymphatic system， and gastrointestinal system， etc； the preferred terminologies （PT） with intense signal were hypofibrinogenaemia and blood fibrinogen decreased. Fourteen ADE signals were not mentioned in the drug instruction， such as renal failure， acute kidney injury and hemorrhage. Totally 24 ADE positive signals of omadacycline were mined， involving 6 SOCs， mainly concentrated in the gastrointestinal system and various examinations； the PTs with intense signals were tooth discoloration， jet-like vomiting and loose feces， etc. ADE signals were not mentioned in the drug instructions， included lip swelling， gastroesophageal reflux disease， eosinophilia， skin discoloration， feces softening， and night sweats. Five ADE positive signals of eravacycline were mined， involving 4 SOCs， mainly concentrated in various examinations， gastrointestinal system， etc. The most intense ADE signals were blood fibrinogen decreased and hypofibrinogenaemia. CONCLUSIONS ADE of the gastrointestinal system are mostly identified in the three third-generation tetracycline antibiotics， especially pancreatitis caused by tigecycline and gastroesophageal reflux disease caused by oral administration of omadacycline. The liver function， renal function （for tigecycline） and coagulation function （for tigecycline， eravacycline） should be monitored biyiliang@hotmail.com regularly during medication， so as to prevent the occurrence of serious ADE.

Hypoxic postconditioning protects myocardium by regulating autophagy in aging cardiomyocytes through piRNA-005854 / 中国组织工程研究

BACKGROUND:Ischemic postconditioning is one of the effective ways to reduce ischemia-reperfusion injury and has been more and more widely used in clinical practice in recent years,but its specific molecular mechanism has yet to be studied. OBJECTIVE:To investigate the role and mechanism of piRNA-005854 in the aging cardiomyocytes caused by hypoxic postconditioning. METHODS:In vitro,cardiomyocytes were administered 8 mg/mL D-galactose for 9 days to induce their aging.β-Galactosidase staining was used to observe the aging of cardiomyocytes.Senescent cells were treated with hypoxia/reoxygenation and hypoxic postconditioning.ELISA was utilized to detect changes in myocardial injury markers creatine kinase isoenzyme MB and lactate dehydrogenase levels.Western blot assay was applied to detect the expression changes of autophagy-related proteins LC3II,p62,ULK1 and phosphorylated ULK1 in aging cardiomyocytes.qRT-PCR was employed to determine the expression level of piRNA-005854.piRNA-005854 inhibitor and piRNA-005854 mimics were transferred into aging cardiomyocytes and followed with hypoxic postconditioning.Western blot assay was used to examine the expression of LC3II,p62,ULK1 and phosphorylated ULK1. RESULTS AND CONCLUSION:(1)D-galactose induced obvious senescence of cardiomyocytes 9 days later.(2)Compared with the normoxia group,creatine kinase isoenzyme MB and lactate dehydrogenase levels increased in the hypoxia/reoxygenation group(P<0.01);LC3 II/I expression was increased;p62 expression was decreased;ULK1 phosphorylation level was increased,and piRNA-005854 expression was increased(P<0.01).(3)Compared with the hypoxia/reoxygenation group,creatine kinase isoenzyme MB and lactate dehydrogenase levels significantly reduced in the hypoxic postconditioning group(P<0.01);LC3 II/I expression significantly decreased(P<0.05);p62 expression increased(P<0.01);ULK1 phosphorylation level decreased(P<0.05),and piRNA-005854 expression decreased(P<0.01).(4)After transfection of piRNA-005854 inhibitor,LC3II/I expression was decreased(P<0.01);the expression of p62 was increased significantly(P<0.05);the phosphorylation level of ULK1 was decreased significantly(P<0.01).After transfection of piRNA-005854 mimics,LC3II/I expression was increased significantly;the expression of p62 was decreased,and the phosphorylation level of ULK1 was increased significantly(P<0.01).(5)The results show that piRNA-005854-mediated reduction of ULK1-dependent autophagy level is a possible mechanism that hypoxic postconditioning exerts its protective effect on aging cardiomyocytes.

Case 02 (2024): Acute ST-segment elevation myocardial infarction during pregnancy caused by coronary artery dissection: a case report / 中华围产医学杂志

This article presents a case of acute ST-segment elevation myocardial infarction (STEMI) in a pregnant woman caused by coronary artery dissection. The 41-year-old patient had undergone cardiac valve surgery at the age of 1 and had no risk factors such as hypertension, diabetes, smoking, alcohol use, or a family history of coronary artery disease. At 31 +1 weeks of gestation, she experienced sudden chest pain for 4 hours and was emergently referred to Peking University First Hospital on June 1, 2021. Electrocardiogram revealed ST-segment elevation in leads I, aVL, and V 2 to V 6. Biochemical assays showed elevated levels of high-sensitivity cardiac troponin I and creatine kinase-MB. Echocardiography indicated segmental ventricular wall motion abnormalities (apical) and reduced left ventricular function, confirming the diagnosis of acute anterior wall STEMI. The patient promptly underwent emergency coronary angiography and percutaneous coronary intervention and confirmed coronary artery dissection. Postoperative care included antiplatelet, anticoagulation, and supportive treatment. At 34 +3 weeks of gestation, with the condition of acute anterior wall STEMI being relatively stable, a cesarean section was successfully performed. Regular cardiology follow-ups were scheduled postpartum, and cardiac function was normal in two years after discharge.

Work despite of wind and rain, pass on the flame through generations: 25 years of history of Chinese Journal of Perinatal Medicine / 中华围产医学杂志

November 2023 marks the 110th anniversary of the birth of Yan Renying, the "Mother of Chinese Perinatal Health Care". The year 2023 was also the 35th anniversary of the founding of the Society of Perinatal Medicine of the Chinese Medical Association, and the 25th anniversary of the founding of the Chinese Journal of Perinatal Medicine.This article summarizes the development of perinatal medicine in China and the academic work and achievements of this journal from two aspects: the management of hyperglycemia in pregnancy for promoting the health of the whole life cycle of the mother and infant and the early identification and comprehensive management of placenta accreta spectrum disorders. It is proposed that in the future, the journal should pay more attention to the articles regarding the priority of prophylaxis and perinatal management on the long-term health of mothers and infants, aiming to promote the prevention of adult diseases from early life.

Progress in antenatal magnesium sulfate exposure for neuroprotection in preterm infants / 中华围产医学杂志

Magnesium sulfate has been administered to pregnant women at imminent risk of preterm delivery for fetal neuroprotection, but its adverse effects and target population have not been fully studied. This paper summarizes the current protocols according to the existing guidelines and the latest research progress, including the gestational age at intervention, dose, duration of therapy and the need for re-administration, hoping to provide a reference for the clinical use of magnesium sulfate for fetal neuroprotection in China.

Great obstetrics syndromes: re-examining the nature of obstetric diseases / 中华围产医学杂志

The introduction of the word "great obstetrics syndromes (GOS)" emphasizes the exploration of the etiology of obstetric diseases and the investigation of effective obstetric disease prevention and prediction strategies. Subsequently, disease prevention and treatment at an early stage becomes feasible, allowing intervention before the occurrence and progression of the condition. This approach enables the realization of precision medicine in obstetric diseases and enhances the diagnosis and treatment of obstetric complications. This paper summarizes the characteristics of GOS and the challenges it reveals to obstetrics. Its objective is to assist obstetricians in obtaining a comprehensive understanding of GOS, re-examining the nature and distinctiveness of obstetric diseases, and collaborating towards advancement in obstetrical medicine.

Effectiveness and safety of intra-amniotic ethacridine injection for third trimester induction due to fetal demise / 中华围产医学杂志

Objective:To study the effectiveness and safety of intra-amniotic ethacridine injection in pregnancy induction at ≥28 gestational weeks due to fetal demise.Methods:This retrospective study recruited 77 singleton pregnant women who were admitted to Peking University First Hospital at ≥28 gestational weeks, from January 1, 2011 to December 31, 2021, because of fetal demise diagnosed by ultrasound. Four groups were classified according to different methods of induction, including ethacridine success group ( n=63), ethacridine failure group ( n=4), mifepristone plus misoprostol group ( n=5), and spontaneous delivery group ( n=5). Those in the ethacridine success group were further divided into scarred and non-scarred uterus group. The differences in general conditions and delivery outcomes among these women were analyzed using t-test, one-way analysis of variance, Chi-square test, and Mann-Whitney U test or Kruskal-Wallis H test. Results:(1) Among the 67 patients induced by ethacridine, the success rate was 94.0% (63/67). (2) Compared the ethacridine success group with the mifepristone plus misoprostol group or spontaneous delivery group, respectively, there was no significant difference in total labor duration, intrapartum hemorrhage volume, weight of the dead fetus, and the incidence of postpartum hemorrhage, perineal laceration, and intrauterine residue (all P>0.05). No serious complications such as placental abruption, disseminated intravascular coagulation, intrauterine infection, uterine rupture, conversion to cesarean section, or puerperal infection occurred in the three groups. (3) The duration between ethacridine injection and labor onset was shorter in the ethacridine success group than in the mifepristone plus misoprostol group [(28.5±12.0) h vs (54.2±17.6) h, t=－4.45, P<0.001]. (4) Among the 63 cases of ethacridine success group, the outcomes after induction were similar between scarred and non-scarred uterus group (all P>0.05). (5) The median duration between ethacridine injection and labor onset in the ethacridine success group was 26.8 h (2.3-66.0 h), which meant 95% of the patients went into labor within 51.7 h and 100% within 66 h after the injection. Conclusion:Intra-amniotic injection of ethacridine is safe and effective in termination for singleton pregnancy due to fetal demise at the third trimester and the duration from drug administration to labor onset was significantly shorter than that of mifepristone plus misoprostol, without increasing the risk of any complications.

Diabetic ketoacidosis in pregnancy: a retrospective analysis of ten cases / 中华围产医学杂志

Objective:To analyze the clinical features, prevention, and treatment of diabetic ketoacidosis (DKA) in pregnancy.Methods:Clinical features, treatment, and pregnancy outcomes of ten pregnant patients diagnosed with DKA and treated at Peking University First Hospital from January 2004 to December 2021 were analyzed retrospectively using descriptive statistical analysis.Results:DKA was found in two cases in the first trimester, three in the second trimester, and five in the third trimester, respectively. Six had type 1 diabetes (including two patients with fulminant type 1 diabetes) and four patients had type 2 diabetes. Only two cases received regular pregnancy examinations, and two began prenatal care in the second trimester. The other six cases neither had prenatal examination nor regular examination. Infection, pancreatitis, and preeclampsia occurred in six, two, and one case, respectively, and among them, four had urinary system infection. Laboratory examination showed that the average pH, blood glucose, and glycated hemoglobin A1c (HbA1c) at onset were 7.06±0.16, (23.7±2.6) mmol/L and (9.2±0.8)%. All patients had different degrees of electrolyte disorder and tested positive for urine ketone bodies. After rehydration, glucose-lowering, and correction of electrolyte disorder, the acidosis was relieved, and the ketone bodies turned negative in all patients. There was no maternal death. The fetal loss occurred in five cases, including one with intrauterine fetal death in late pregnancy, one with embryo arrest in early pregnancy, one with unavoidable abortion, and two terminated on maternal request. The remaining three were term labor and two were preterm labor.Conclusions:The leading cause of DKA in pregnancy is poor control of diabetic blood glucose, followed by infection. Once DKA is complicated during pregnancy, the outcome of the mother and her baby is poor. Its occurrence should be actively prevented. For women with fulminant type 1 diabetes, DKA is easier to occur, and the prognosis is poorer, so strict management and follow-up should be warranted.

Polycystic ovary syndrome and spontaneous preterm birth / 中华围产医学杂志

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among reproductive-age women, characterized by obesity, insulin resistance, chronic low-grade inflammation, and hyperandrogenemia. Studies have revealed that women with PCOS may experience an increased risk of various adverse pregnancy outcomes, such as gestational diabetes, hypertensive disorders of pregnancy, miscarriages, and preterm births. Preterm birth is an important cause of adverse outcome among perinatal infants. However, due to the complexity of its pathogenesis, the current intervention treatment of preterm birth often yields unsatisfactory results. Recent studies have discovered that women with PCOS have a higher risk of preterm birth than those without, suggesting that PCOS is a risk factor for preterm birth. This article reviews the research progress of PCOS-related preterm birth to offer new insights into the prevention and treatment of preterm birth in women caused by PCOS.

Perinatal management of stenosis or premature closure of ductus arteriosus in three fetuses / 中华围产医学杂志

Objective:To summarize the features of stenosis or premature closure of fetal ductus arteriosus and to investigate the perinatal management strategies.Methods:Three cases diagnosed with stenosis or premature closure of fetal ductus arteriosus in Peking University First Hospital between January 2022 and June 2022 were retrospectively enrolled. Clinical features and perinatal management strategies were summarized.Results:Fetal cardiac abnormalities (right heart enlargement and tricuspid regurgitation) were detected in the three cases by routine prenatal ultrasound at the gestational weeks of 24, 30 and 23, respectively. Fetal echocardiography confirmed the diagnosis of stenosis or premature closure of fetal ductus arteriosus and no other structural anomalies were detected. All three pregnant women denied taking non-steroidal anti-inflammatory drugs. Case 1 and case 2 underwent emergency cesarean section due to suspected fetal cardiac dysfunction with a cardiovascular profile score of 6 and 5. The two neonates were transferred to the neonatal intensive care unit and discharged with good prognosis (normal cardiac function) on the 56th and 42nd day after birth. During a close monitoring, the stenosis of fetal ductus arteriosus improved in case 3 and a full-term neonate was delivered at 38 weeks by elective cesarean section because of a history of cesarean section.Conclusions:In the second and third trimesters of pregnancy, attention should be drawn to the fetal ductus arteriosus during ultrasound imaging, especially when right heart enlargement and tricuspid regurgitation were detected. For fetuses with suspected ductus arteriosus stenosis, a close monitor of the ductus arteriosus and the ultrasound findings indicating cardiac dysfunction is needed and the cardiovascular profile score should also be involved. Fetuses with premature closure of the ductus arteriosus should be delivered promptly and the postnatal cardiac outcomes are good.

Cervical length changes in singleton pregnancies following history-indicated cerclage and their impact on preterm birth <34 weeks of gestation / 中华围产医学杂志

Objective:To investigate the changes in cervical length (CL) after history- indicated cerclage through serial ultrasound measurements and the predictive value of short cervix (CL≤2.5 cm) before 24 gestational weeks after cerclage in preterm delivery before 34 weeks.Methods:In this retrospective study, clinical data of 145 singleton pregnancies with history-indicated McDonald cerclage at Peking University First Hospital from January 2010 to June 2021 were collected. CL was measured through transvaginal ultrasound and recorded during the perioperative period and at ≥20-24, ≥24-28, and ≥28-32 weeks of gestation. The participants were divided into ≥34 weeks group ( n=118) and <34 weeks group ( n=27) based on the gestational age at delivery. Chi-square or independent sample t test was applied for comparison between the two groups. The relationship between CL after cerclage and preterm birth before 34 week in the two groups was analyzed using multivariate logistic regression analysis. The risk of preterm birth in women with short cervix at 20-24 weeks of gestation after cerclage was estimated. The receiver operator characteristic curve was adopted for predicting the diagnostic value of postoperative CL on pregnancy outcomes. Results:(1) Among the 145 cases, 106 cases (73.1%) had term delivery, 27 cases (18.6%) had premature delivery before 34 weeks, among which seven cases (4.8%) had late miscarriage before 28 weeks (including two cases with survived viable infants). The overall live birth rate was 96.6% (140/145). (2) In the ≥34 weeks group, CL at ≥20-24, ≥24-28, and ≥28-32 weeks of gestation were significantly longer than those in the <34 weeks group [(3.35±0.73) vs (2.39±1.03) cm, t=5.69, P=0.008; (3.14±0.75) vs (2.14±1.10) cm, t=5.65, P=0.007; (2.91±0.85) vs (1.79±1.09) cm, t=5.84, P=0.005]. (3) Multivariate logistic regression analysis showed that CL at ≥20-24, ≥24-28, and ≥28-32 weeks after cerclage were the influencing factors of preterm birth before 34 weeks [ OR (95% CI)=0.885 (0.837-0.935), 0.886 (0.837-0.937), 0.890 (0.842-0.940), respectively, all P<0.001]. (4) The area under the curve of CL at ≥20-24, ≥24-28, and ≥28-32 weeks were 0.747, 0.734, and 0.799 for predicting delivery before 34 weeks, with the sensitivity of 60.0%, 60.0%, and 80.0%, and the specificity of 87.5%, 91.3%, and 76.9%, respectively. (5) At ≥20-24 weeks after cervical cerclage, women with a short cervix accounted for 17.2% (25/145), who were 12.7 times more likely to have premature birth before 34 weeks than those with a CL over 2.5 cm ( OR=12.7, 95% CI: 4.58-35.40, P<0.001). Conclusions:Among pregnant women with history-indicated cervical cerclage, CL after cerclage at ≥20-24, ≥24-28, and ≥28-32 weeks of gestation have predictive values for pregnancy outcomes. A short cervix at ≥20-24 weeks of pregnancy after cerclage could predict premature birth before 34 weeks.

Recommendations for the diagnosis and treatment of maternal SARS-CoV-2 infection / 中华围产医学杂志

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has spread worldwide and threatened human's health. With the passing of time, the epidemiology of coronavirus disease 2019 evolves and the knowledge of SARS-CoV-2 infection accumu-lates. To further improve the scientific and standardized diagnosis and treatment of maternal SARS-CoV-2 infection in China, the Chinese Society of Perinatal Medicine of Chinese Medical Association commissioned leading experts to develop the Recommendations for the Diagnosis and Treatment of Maternal SARS-CoV-2 Infection under the guidance of the Maternal and Child Health Department of the National Health Commission. This recommendations includes the epidemiology, diagnosis, management, maternal care, medication treatment, care of birth and newborns, and psychological support associated with maternal SARS-CoV-2 infection. It is hoped that the recommendations will effectively help the clinical management of maternal SARS-CoV-2 infection.

Comparison of clinical features in antepartum and postpartum HELLP syndrome / 中华妇产科杂志

Objective:To analyze the clinical features and pregnancy outcomes in antepartum and postpartum hemolysis, elevated live enzymes, and low platelet count syndrome(HELLP syndrome).Methods:A retrospective study was conducted to collect maternal and neonatal information of pre-eclampsia complicated with HELLP syndrome in Peking University First Hospital during the ten years from April 2009 to March 2019. A total of 83 pregnant women were included according to the Tennessee Classification System. They were then allocated into two groups based on the onset time of HELLP syndrome: antepartum HELLP syndrome group ( n=70) and postpartum HELLP syndrome group ( n=13). The clinical features, symptoms, laboratory biomarkers, and pregnancy outcomes were compared between the two groups. Results:Among the 83 pregnant women with HELLP syndrome, 70 occurred prenatally (84%, 70/83) and 13 occurred postpartum (16%, 13/83). The twin or triplet pregnancy rate in the postpartum HELLP syndrome group was significantly higher than that in the antepartum HELLP syndrome group [6/13 vs 6% (4/70), P=0.001]. The gestational weeks for HELLP onset and delivery in the postpartum HELLP syndrome group were significantly later than those in the antepartum HELLP syndrome group [(35.8±3.0) vs (31.5±5.2) weeks, P=0.025; (36.7±2.3) vs (32.2±5.0) weeks, P=0.002]. The incidence of early-onset pre-eclampsia in the antepartum HELLP syndrome group was significant higher than that in the postpartum HELLP syndrome group [64% (45/70) vs 2/13, P=0.002]. The quantitative of 24-hour proteinuria was significant higher in the antepartum HELLP syndrome group than that in the postpartum HELLP syndrome group [(4.8±5.1) vs (1.8±1.6) g, P=0.002]. But there were no statistical significances in the comparison of other laboratory test indexes (all P>0.05). There were no significant differences between the two groups in clinical symptoms, severe maternal complications, transfusion or adverse maternal outcomes (all P>0.05). Conclusions:Antepartum and postpartum HELLP syndrome have similar clinical symptoms and laboratory characteristics. Both antepartum and postpartum HELLP syndrome could lead to severe maternal complications, which should be paid special attention in clinical practice, especially to the postpartum HELLP syndrome.

Pedigree analysis for prenatal screening and diagnosis / 中华围产医学杂志

The information arising from pedigree analysis is important for clinicians to understand the inheritance pattern of the disease, filter the testing data, and provide suggestions to other family members. Along with the development and clinical implementation of new genetic testing, an increasing number of "positive" results are obtained and pedigree analysis is required to further verify the pathogenicity.

Progress on association of obesity with common congenital heart diseases and its underlying mechanisms / 中华围产医学杂志

Maternal obesity is associated with an increased risk of a range of congenital malformations in offspring, including neurological malformations, congenital heart disease, congenital kidney and urinary system abnormalities, cleft lip and palate, anorectal atresia, etc. This may be related to existing metabolic abnormalities, including increased insulin resistance, chronic inflammation, and oxidative stress caused by excessive accumulation of fat, as well as the relative deficiency of nutrients such as folic acid in obese pregnant women. Therefore, it is recommended that obese women have a planned pregnancy, address folate and micronutrient supplementation and optimize their health status prior to conception.

On management of mild hypertension during pregnancy / 中华围产医学杂志

It has been accepted that pregnant women should receive antihypertensive therapy when the blood pressure is ≥160/110 mmHg (1 mmHg=0.133 kPa). However, a consensus is yet to be reached worldwide regarding whether lowering blood pressure is required for pregnant women with mild hypertension (blood pressure <160/110 mmHg). Diagnosis and treatment of hypertension and pre-eclampsia in pregnancy: a clinical practice guideline in China (2020) recommends that pregnant women whose blood pressure are ≥140/90 mmHg should be treated with antihypertensive therapy. A recent study has shown that antihypertensive therapy for pregnant women with blood pressure over 140/90 mmHg could improve the pregnancy outcomes, providing further evidence for the recommendation in the 2020 guideline in China. Current studies have shown that the risk of adverse pregnancy outcomes increases in pregnant women with normal high blood pressure (130-139/80-89 mmHg), which indicates that effective management measures such as close monitoring should be conducted for this population, in order to reduce the adverse pregnancy outcomes.

Discussion on prenatal corticosteroids for fetal lung maturation / 中华围产医学杂志

Prenatal corticosteroid for fetal lung maturation has been widely used in daily practice in obstetrics. However, previous research showed that prenatal corticosteroids may increase the risk of neonatal hypoglycemia and birth weight loss. And it remains controversial regarding the dosage and repeated administration. Based on the guideline "Antenatal corticosteroids to reduce neonatal morbidity and mortality" published by Royal College of Obstetricians and Gynaecologists in February 2022, here we are going to discuss several issues on the usage of prenatal corticosteroids.

Focus on nutrition and metabolic diseases during pregnancy to improve life cycle health / 中华围产医学杂志

As illustrated by the concept of the developmental origins of health and diseases (DOHaD) and the first 1000 days, early life is essential for preventing adult diseases. A sharper focus on intervention during pregnancy and even before conception is needed to improve maternal and child health. Pregnant women should be encouraged to adopt a balanced diet to enhance the status of undernutrition and overnutrition. A balanced diet and physical exercise are significant to ensure appropriate weight gain during pregnancy. A healthy lifestyle should be guaranteed and continued throughout the life cycle, and breastfeeding should be encouraged to prevent adult disease risk and improve life cycle health.

Progress in genetic epidemiology of gestational diabetes mellitus / 中华围产医学杂志

Gestational diabetes mellitus poses a substantial threat to the short- and long-term health of women and their offspring. Previous studies have identified a number of genetic risk factors for gestational diabetes through candidate gene strategy and whole genome studies. Many of these identified genetic variations have also been proved to be associated with type 2 diabetes, abnormal glycometabolism as well as insulin secretion and resistance. This article reviews the recent progress in the genetic epidemiology of gestational diabetes mellitus.